The role of T helper cells in neuroprotection and regeneration

Journal of Neuroimmunology

Volumn 184, Issue 1-2, 2007, Pages 100-112

  Hendrix, Sven ^a   Nitsch, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CNS wound healing; Immunosuppression; Protective autoimmunity; Spinal cord injury; Th2; Traumatic brain injury

Indexed keywords

ALUMINUM HYDROXIDE; ALZHEIMER DISEASE VACCINE; ATORVASTATIN; CERIVASTATIN; FREUND ADJUVANT; GLATIRAMER; IMMUNOLOGICAL ADJUVANT; MEVINOLIN; SIMVASTATIN;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL INFILTRATION; CELL SUBPOPULATION; CLINICAL TRIAL; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE; TH2 CELL; WOUND HEALING;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NERVE DEGENERATION; REGENERATION; TH2 CELLS; WOUND HEALING;

EID: 33847631663     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.11.019     Document Type: Review

References (105)

1. Aktas O., Waiczies S., Smorodchenko A., Dorr J., Seeger B., Prozorovski T., Sallach S., Endres M., Brocke S., Nitsch R., and Zipp F. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197 (2003) 725-733
2. Angelov D.N., Waibel S., Guntinas-Lichius O., Lenzen M., Neiss W.F., Tomov T.L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., and Schwartz M. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4790-4795
3. Arora M., Chen L., Paglia M., Gallagher I., Allen J.E., Vyas Y.M., Ray A., and Ray P. Simvastatin pro motes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7777-7782
4. Babcock A.A., Kuziel W.A., Rivest S., and Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal in jury in the CNS. J. Neuro. Sci. 23 (2003) 7922-7930
5. Bakalash S., Shlomo G.B., Aloni E., Shaked I., Wheeler L., Ofri R., and Schwartz M. T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. J. Mol. Med. 83 (2005) 904-916
6. Bechmann I., Peter S., Beyer M., Gimsa U., and Nitsch R. Presence of B7-2 (CD86) and lack of B7-1 (CD(80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. FASEB J. 15 (2001) 1086-1088
7. Benner E.J., Mosley R.L., Destache C.J., Lewis T.B., Jackson-Lewis V., Gorantla S., Nemachek C., Green S.R., Przedborski S., and Gendelman H.E. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9435-9440
8. Biedermann T., Rocken M., and Carballido J.M. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J. Investig. Dermatol. Symp. Proc. 9 (2004) 5-14
9. Bishop G.M., Robinson S.R., Smith M.A., Perry G., and Atwood C.S. Call for Elan to publish Alzheimer's trial details. Nature 416 (2002) 677
10. Byram S.C., Carson M.J., DeBoy C.A., Serpe C.J., Sanders V.M., and Jones K.J. CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J. Neurosci. 24 (2004) 4333-4339
11. Caruso C., Candore G., Cigna D., DiLorenzo G., Sireci G., Dieli F., and Salerno A. Cytokine production pathway in the elderly. Immunol. Res. 15 (1996) 84-90
12. Castle S., Uyemura K., Wong W., Modlin R., and Effros R. Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents. Mech. Ageing Dev. 94 (1997) 7-16
13. Check E. Nerve inflammation halts trial for Alzheimer's drug. Nature 415 (2002) 462
14. Cherwinski H.M., Schumacher J.H., Brown K.D., and Mosmann T.R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166 (1987) 1229-1244
15. Comoy E.E., Capron A., and Thyphronitis G. In vivo induction of type 1 and 2 immune responses against protein antigens. Int. Immunol. 9 (1997) 523-531
16. Cox J.C., and Coulter A.R. Adjuvants - a classification and review of their modes of action. Vaccine 15 (1997) 248-256
17. Dayan M., Segal R., Globerson A., Habut B., Shearer G.M., and Mozes E. Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus-afflicted mice. Exp. Gerontol. 35 (2000) 225-236
18. Dhib-Jalbut S., Chen M., Said A., Zhan M., Johnson K.P., and Martin R. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype. J. Neuroimmunol. 140 (2003) 163-171
19. Duda P.W., Schmied M.C., Cook S.L., Krieger J.I., and Hafler D.A. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 105 (2000) 967-976
20. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26 (2005) 485-495
21. Engwerda C.R., Fox B.S., and Handwerger B.S. Cytokine production by T lymphocytes from young and aged mice. J. Immunol. 156 (1996) 3621-3630
22. Ernst D.N., Weigle W.O., and Hobbs M.V. Aging and lymphokine production by T cell subsets. Stem Cells 11 (1993) 487-498
23. Farina C., Then Bergh F., Albrecht H., Meinl E., Yassouridis A., Neuhaus O., and Hohlfeld R. Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells. Brain 124 (2001) 705-719
24. Fee D., Crumbaugh A., Jacques T., Herdrich B., Sewell D., Auerbach D., Piaskowski S., Hart M.N., Sandor M., and Fabry Z. Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. J. Neuroimmunol. 136 (2003) 54-66
25. Fisher J., Levkovitch-Verbin H., Schori H., Yoles E., Butovsky O., Kaye J.F., Ben-Nun A., and Schwartz M. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J. Neurosci. 21 (2001) 136-142
26. Francis J.N., and Durham S.R. Adjuvants for allergen immunotherapy: experimental results and clinical perspectives. Curr. Opin. Allergy Clin Immunol. 4 (2004) 543-548
27. Frasca D., Pucci S., Goso C., Barattini P., Barile S., Pioli C., and Doria G. Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells. Mech. Ageing Dev. 93 (1997) 157-169
28. Frenkel D., Huang Z., Maron R., Koldzic D.N., Hancock W.W., Moskowitz M.A., and Weiner H.L. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J. Immunol. 171 (2003) 6549-6555
29. Frenkel D., Huang Z., Maron R., Koldzic D.N., Moskowitz M.A., and Weiner H.L. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 233 (2005) 125-132
30. Gimsa U., Wolf S.A., Haas D., Bechmann I., and Nitsch R. Th2 cells support intrinsic anti-inflammatory properties of the brain. J. Neuro. Immunol. 119 (2001) 73-80
31. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., and Quaglino D. The immune system in the elderly: III. Innate immunity. Immunol. Res. 20 (1999) 117-126
32. Gran B., Tranquill L.R., Chen M., Bielekova B., Zhou W., Dhib-Jalbut S., and Martin R. Mechanisms of immunomodulation by glatiramer acetate. Neurology 55 (2000) 1704-1714
33. Grun J.L., and Maurer P.H. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell. Immunol. 121 (1989) 134-145
34. Hakamada-Taguchi R., Uehara Y., Kuribayashi K., Numabe A., Saito K., Negoro H., Fujita T., Toyo-oka T., and Kato T. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ. Res. 93 (2003) 948-956
35. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20 (2000) 5283-5291
36. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20 (2000) 6421-6430
37. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Auto immune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355 (2000) 286-287
38. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., and Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding auto immune disease. J. Clin. Invest. 108 (2001) 591-599
39. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., and Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15173-15178
40. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11 (1999) 125-137
41. Hickey W.F., and Kimura H. Graft- vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 2082-2086
42. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28 (1991) 254-260
43. Hirschberg D.L., Moalem G., He J., Mor F., Cohen I.R., and Schwartz M. Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J. Neuroimmunol. 89 (1998) 88-96
44. Hofstetter H.H., Sewell D.L., Liu F., Sandor M., Forsthuber T., Lehmann P.V., and Fabry Z. Autoreactive T cells promote post-traumatic healing in the central nervous system. J. Neuroimmunol. 134 (2003) 25-34
45. Hohlfeld R., and Dalakas M.C. Basic principles of immunotherapy for neurologic diseases. Semin. Neurol. 23 (2003) 121-132
46. Huang D.W., McKerracher L., Braun P.E., and David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24 (1999) 639-647
47. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., and Westaway D. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408 (2000) 979-982
48. Jones T.B., Basso D.M., Sodhi A., Pan J.Z., Hart R.P., MacCallum R.C., Lee S., Whitacre C.C., and Popovich P.G. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neuro. Sci. 22 (2002) 2690-2700
49. Jones T.B., Ankeny D.P., Guan Z., McGaughy V., Fisher L.C., Basso D.M., and Popovich P.G. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci. 24 (2004) 3752-3761
50. Kariv I., Ferguson F.G., and Confer F.L. Age- and strain-related differences in murine spleen cell responses to different activation signals. Cell. Immunol. 140 (1992) 67-80
51. Kigerl K.A., McGaughy V.M., and Popovich P.G. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 494 (2006) 578-594
52. Kil K., Zang Y.C., Yang D., Markowski J., Fuoco G.S., Vendetti G.C., Rivera V.M., and Zhang J.Z. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J. Neuroimmunol. 98 (1999) 201-207
53. Killen J.A., and Swanborg R.H. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis. J. Immunol. 129 (1982) 759-763
54. Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I.R., and Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7446-7451
55. Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., and Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 21 (2001) 4564-4571
56. Kipnis J., Mizrahi T., Yoles E., Ben-Nun A., Schwartz M., and Ben-Nur A. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 130 (2002) 78-85
57. Kipnis J., Nevo U., Panikashvili D., Alexandrovich A., Yoles E., Akselrod S., Shohami E., and Schwartz M. Therapeutic vaccination for closed head injury. J. Neurotrauma 20 (2003) 559-569
58. Kivisakk P., Mahad D.J., Callahan M.K., Trebst C., Tucky B., Wei T., Wu L., Baekkevold E.S., Lassmann H., Staugaitis S.M., Campbell J.J., and Ransohoff R.M. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8389-8394
59. Kubo M., and Cinader B. Polymorphism of age-related changes in interleukin (IL) production: differential changes of T helper subpopulations, synthesizing IL 2, IL 3 and IL 4. Eur. J. Immunol. 20 (1990) 1289-1296
60. Liew F.Y. T(H)1 and T(H)2 cells: a historical perspective. Nat. Rev. Immunol. 2 (2002) 55-60
61. Lu D., Goussev A., Chen J., Pannu P., Li Y., Mahmood A., and Chopp M. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J. Neurotrauma 21 (2004) 21-32
62. Lu D., Mahmood A., Goussev A., Schallert T., Qu C., Zhang Z.G., Li Y., Lu M., and Chopp M. Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J. Neurosurg. 101 (2004) 813-821
63. Lu D., Mahmood A., Qu C., Goussev A., Lu M., and Chopp M. Atorvastatin reduction of intracranial hematoma volume in rats subjected to controlled cortical impact. J. Neurosurg. 101 (2004) 822-825
64. McGeachy M.J., and Anderton S.M. Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis. Cytokine 32 (2005) 81-84
65. Meisel C., Schwab J.M., Prass K., Meisel A., and Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6 (2005) 775-786
66. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5 (1999) 49-55
67. Moalem G., Monsonego A., Shani Y., Cohen I.R., and Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13 (1999) 1207-1217
68. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., and Arendash G.W. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408 (2000) 982-985
69. Mosmann T.R., Cherwinski H., Bond M.W., and Coffman M.A. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136 (1986) 2348-2357
70. Namikawa T., Richert J.R., Driscoll B.F., Kies M.W., and Alvord Jr. E.C. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant. J. Immunol. 128 (1982) 932-934
71. Neuhaus O., Farina C., Yassouridis A., Wiendl H., Then Bergh F., Dose T., Wekerle H., and Hohlfeld R. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7452-7457
72. Olsson T., Diener P., Ljungdahl A., Hojeberg B., van der Meide P.H., and Kristensson K. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Auto Immun. 13 (1992) 117-126
73. Olsson T., Sun J.B., Solders G., Xiao B.G., Hojeberg B., Ekre H.P., and Link H. Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J. Neurol. Sci. 117 (1993) 130-139
74. Pannu R., Barbosa E., Singh A.K., and Singh I. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J. Neurosci. Res. 79 (2005) 340-350
75. Parish C.R. The relationship between humoral and cell-mediated immunity. Transplant. Rev. 13 (1972) 35-66
76. Parronchi P., Macchia D., Piccinni M.P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A.A., and Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4538-4542
77. Pollock K.G., Conacher M., Wei X.Q., Alexander J., and Brewer J.M. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 108 (2003) 137-143
78. Popovich P.G., and Jones T.B. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24 (2003) 13-17
79. Popovich P.G., Stokes B.T., and Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45 (1996) 349-363
80. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., and Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198 (2003) 725-736
81. Qu C., Lu D., Goussev A., Schallert T., Mahmood A., and Chopp M. Effect of atorvastatin on spatial memory, neuronal survival, and vascular density in female rats after traumatic brain injury. J. Neurosurg. 103 (2005) 695-701
82. Sandmand M., Bruunsgaard H., Kemp K., Andersen-Ranberg K., Pedersen A.N., Skinhoj P., and Pedersen B.K. Is ageing associated with a shift in the balance between type 1 and type 2 cytokines in humans?. Clin. Exp. Immunol. 127 (2002) 107-114
83. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
84. Schnell L., Schneider R., Berman M.A., Perry V.H., and Schwab M.E. Lymphocyte recruitment following spinal cord injury in mice is altered by prior viral exposure. Eur. J. Neurosci. 9 (1997) 1000-1007
85. Schnell L., Fearn S., Klassen H., Schwab M.E., and Perry V.H. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11 (1999) 3648-3658
86. Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L.A., and Schwartz M. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3398-3403
87. Schwartz M. T-cell-based vaccination against neurodegeneration: a new therapeutic approach. Retina 25 (2005) S33-S35
88. Schwartz M., Cohen I., Lazarov-Spiegler O., Moalem G., and Yoles E. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J. Mol. Med. 77 (1999) 713-717
89. Segal R., Dayan M., Globerson A., Habut B., Shearer G.M., and Mozes E. Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus afflicted mice. Mech. Ageing Dev. 96 (1997) 47-58
90. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., and Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J. Neurosci. 19 (1999) RC7
91. Serpe C.J., Sanders V.M., and Jones K.J. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J. Neurosci. Res. 62 (2000) 273-278
92. Serpe C.J., Tetzlaff J.E., Coers S., Sanders V.M., and Jones K.J. Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. Brain Behav. Immun. 16 (2002) 808-812
93. Serpe C.J., Coers S., Sanders V.M., and Jones K.J. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav. Immun. 17 (2003) 393-402
94. Shearer G.M. Th1/Th2 changes in aging. Mech. Ageing Dev. 94 (1997) 1-5
95. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
96. Shibaki A., and Katz S.I. Induction of skewed Th1/Th2 T-cell differentiation via subcutaneous immunization with Freund's adjuvant. Exp. Dermatol. 11 (2002) 126-134
97. Sicotte M., Tsatas O., Jeong S.Y., Cai C.Q., He Z., and David S. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol. Cell. Neurosci. 23 (2003) 251-263
98. Stepien K., Tomaszewski M., and Czuczwar S.J. Neuroprotective properties of statins. Pharmacol. Rep. 57 (2005) 561-569
99. Wang W.Z., Olsson T., Kostulas V., Hojeberg B., Ekre H.P., and Link H. Myelin antigen reactive T cells in cerebrovascular diseases. Clin. Exp. Immunol. 88 (1992) 157-162
100. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., and Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 (2006) 677-688
101. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182 (2001) 207-214
102. Wekerle H., Sun D., Oropeza-Wekerle R.L., and Meyermann R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 132 (1987) 43-57
103. Wierenga E.A., Snoek M., de Groot C., Chretien I., Bos J.D., Jansen H.M., and Kapsenberg M.L. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J. Immunol. 144 (1990) 4651-4656
104. Wolf S.A., Fisher J., Bechmann I., Steiner B., Kwidzinski E., and Nitsch R. Neuroprotection by T-cells depends on their subtype and activation state. J. Neuroimmunol. 133 (2002) 72-80
105. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., Bravo M., Mitchell D.J., Sobel R.A., Steinman L., and Zamvil S.S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84